FDA warning letter
Closeout letter
Issue date
10 Sept 2019
Issuing office
Center for Drug Evaluation and Research
Posted date
22 Oct 2019
Subject
CGMP/Active Pharmaceutical Ingredient (API)/Adulterated
Products & Services
Drugs
Issue date
15 Dec 2023